Class / Patent application number | Description | Number of patent applications / Date published |
514112000 | Cyano or isocyano containing | 7 |
20090156561 | Use of Cholinesterase Inhibitors In Smoking Cessation - A method of causing a patient to reduce or cease tobacco use that involves the administration of a cholinesterase inhibitor. | 06-18-2009 |
20110245206 | ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES - This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: | 10-06-2011 |
20140066408 | ANTIOXIDANT INFLAMMATION MODULATORS: C-17 HOMOLOGATED OLEANOLIC ACID DERIVATIVES - This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: | 03-06-2014 |
20150038466 | PAIN RELIEF COMPOUNDS - The present invention relates to the use of compounds for the treatment or prevention of pain in mammals, in particularly in human beings, and also to a process for preparing these compounds. | 02-05-2015 |
20150057252 | PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and diethyl(2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering diethyl(2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. | 02-26-2015 |
20160158252 | PHARMACEUTICAL COMPOSITION AND USE OF DIETHYL (2-CYANOETHYL)PHOSPHONATE - The present invention is directed to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and diethyl (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt thereof. The present invention is directed to a method for treating inflammation, inflammatory-related disorders, or pain, by administering diethyl (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt or solvate thereof to a subject in need thereof. The present invention is also directed to a method of treating an inflammatory skin disease or disorder, such as dermatitis, psoriasis, acne, or rosacea, by administering to the subject (2-cyanoethyl)phosphonate, or a pharmaceutically acceptable salt or solvate thereof, in an amount effective to reduce or eliminate the symptoms of the inflammatory skin disease or disorder. Topical administration and oral administration are preferred route of administration. | 06-09-2016 |
514113000 | Cyano or isocyano bonded directly to a benzene ring | 1 |
20150322100 | POLYSUBSTITUTED ARENES AND SYNTHESIS THEREOF - A compound having general formula (I) | 11-12-2015 |